AQP9 and prostate cancer: PC-3 cell line was androgen-independent prostate cancer cell, therefore, we selected PC-3 initially transfected with AQP9 siRNA, and the knockdown efficiency was observed using RT-qPCR and western blot analysis (Figure 3A,B).